Creatine

Creatine

Creatine is stored in muscle cells as phosphocreatine — a rapid buffer for regenerating ATP (adenosine triphosphate, the cell’s immediate energy currency). When a muscle fires, ATP is consumed in milliseconds; phosphocreatine rebuilds it instantly, before slower metabolic pathways can respond. Saturating this pool through supplementation extends the window of high-intensity output before fatigue sets in. For the broader role of muscle as an organ and training principles, see the muscle module. For the full energy system context, see the ATP metabolism module.

The most studied supplement in sports science, with hundreds of human RCTs (randomized controlled trials) behind it — yet the gap between what the data show and what people believe is unusually wide.

Key takeaways

• 3–5g/day creatine monohydrate — every day, no loading required; saturation in ~4 weeks. Monohydrate is the only form with hundreds of trials behind it
• Strength gains are small but highly reliable — a modest boost on top of resistance training, replicated across dozens of trials
• Brain benefits depend on who you are — clearest in older adults, sleep-deprived people, and vegetarians; small or absent in rested young adults
• Women start with lower creatine stores — after menopause, creatine plus lifting helps muscle and strength, not bone density
• Hair loss is a myth — the single 2009 study (n=20) measured a hormone, not hair; a 2025 RCT measuring hair density found no effect
• Safe at every studied dose in healthy people — expect 1–2kg of water in muscle and a higher creatinine number on bloodwork; ⚠️ pre-existing kidney disease is the one contraindication
• Coffee and creatine are fine together — only chronic high caffeine during a loading phase may interfere
• “Creatine prevents cancer” and “creatine causes cancer” are both unproven — no human study has tested either; the conflicting results come from mice
• Source matters — plain monohydrate from Creapure or Creavitalis certified raw material; skip “advanced” forms and gummies

Creatine Calculator→

How creatine works

Your body uses creatine through a simple, fast reaction:

Phosphocreatine (PCr) + ADP → ATP + Creatine (catalysed by creatine kinase)

Phosphocreatine donates its phosphate group directly to ADP (adenosine diphosphate — the “spent”, phosphate-stripped form of ATP), regenerating ATP in milliseconds — no oxygen needed, no glucose needed. This is the fastest energy system in your body, but the smallest reservoir.

Endogenous synthesis

Your body makes ~1–2g of creatine per day in the liver and kidneys from three amino acids: glycine, arginine, and methionine. This endogenous production is supplemented by dietary intake — omnivores get an additional ~1–2g/day from food (primarily red meat and fish). Vegetarians and vegans get near-zero dietary creatine, relying entirely on endogenous synthesis.

Total body creatine pool: ~120–140g in a 70kg person (~95% stored in skeletal muscle). Supplementation increases this pool by ~20%, extending the high-power window before fatigue.

The phosphocreatine (PCr) shuttle

Besides buffering energy at the point of contraction, creatine also carries energy to it. The phosphocreatine shuttle (also called the creatine kinase shuttle) transports high-energy phosphate groups from mitochondria (where ATP is produced) to myofibrils (where ATP is consumed). This spatial energy transport system is particularly important in large muscle cells where diffusion distance between mitochondria and contraction sites is significant.

Muscle & performance

• Strength: a small but highly certain effect — meta-analyses of RCTs put the added strength gain at a standardized effect of ~0.24–0.35 (leg-press to chest-press) on top of resistance training. The largest synthesis to date (69 studies, 2025) confirms the gain is small, significant, and most consistent in younger adults and males, with smaller or non-significant changes in older adults and women; older single-study reviews report this as roughly +5–15% in 1RM (one-rep max). The certainty is Grade A; the magnitude is modest — the two are not the same thing.
• Power output: faster peak force production; measurable in sprint, jump, and explosive effort tests
• Muscle volume: increased intracellular water retention (cell volumisation), plus lean mass gain over training cycles — though how much of that gain is tissue rather than water is now genuinely contested. A 2025 RCT (n=63) ran a 7-day wash-in before the training block specifically to let the water effect settle out of the DXA reading. The wash-in itself added 0.51 kg of “lean mass” in a week, which is faster than tissue accrues. After it, both groups gained 2 kg over 12 weeks of training with no between-group difference. Read it carefully: the control arm got no placebo, so it is unblinded, and the authors suggest a maintenance dose above 5 g/day might be needed. It does not overturn the meta-analytic strength effect above, which is measured as force rather than scale weight. It does suggest some of creatine’s headline “lean mass” number has been water all along, and it comes from inside the pro-creatine research community rather than from sceptics.
• Recovery: lower muscle damage biomarkers (CK, LDH) after hard sessions; faster return to full output
• Endurance buffer: less benefit for pure aerobic work, but helps in high-intensity intervals and repeated sprint protocols

Brain

• Cognitive performance under stress: measurable improvements in reaction time, working memory, and mental fatigue resistance, especially during sleep deprivation or hypoxia (low blood-oxygen states); the effect replicates across (small) trials and is most reliable under metabolic stress
• Sleep deprivation: creatine blunts the cognitive decline from sleep loss. A 2024 crossover trial of one acute high dose (0.35 g/kg) showed better cognition plus higher cerebral phosphocreatine under sleep deprivation; a 2026 trial at a lower single dose (0.2 g/kg) found a modest version of the same protection. A 2026 systematic review reads the overall signal as positive but still sparse and task-dependent. Brain phosphocreatine buffers ATP recycling when sleep-dependent recovery is compromised. (Evidence that creatine improves normal sleep quality or duration is not yet established — see the sleep module.)
• Older adults: a large-magnitude effect (standardized mean difference, SMD ~0.88) in adults 66–76 — though from a B-grade base of small trials, not an A; brain phosphocreatine declines with age and supplementation partially restores it. A 2026 systematic review finds most studies in older adults report a positive cognition signal, especially for memory and attention
• Healthy young adults at rest: evidence is weak and dose/duration-dependent. The largest RCT to date (n=123) found Bayesian evidence for a small beneficial effect on working memory, but below the threshold for a practically meaningful cognitive boost in unstressed young adults; a 16-RCT meta-analysis likewise placed the memory benefit (SMD ~0.31) in older, diseased, and female groups rather than healthy young adults. A 2026 review cautions that brain-creatine uptake is slower and less certain than muscle’s — the dose-response is still being established — and a 2024 skeptical systematic review concludes the cognitive payoff is equivocal even though the brain-creatine rise itself is real.
• Vegetarians: lower brain creatine baseline means larger cognitive response to supplementation; an early double-blind RCT (2003) found vegetarians gained measurably on working-memory and reasoning tasks
• Neuroprotection: early, preliminary evidence for reduced damage markers after mild traumatic brain injury (TBI) and concussion (including in children); not yet a clinical recommendation
• Mood and depression: reviews from 2021 and 2024 report benefit as an adjunct to SSRI antidepressants, especially in women, linked to brain energy metabolism — but the size is small: a 2025 meta-analysis (11 trials) put the antidepressant effect at SMD −0.34 on very-low-quality evidence, below the minimal important difference (the smallest change a patient would notice), so the true benefit may be modest or trivial

Vascular function (emerging)

A newer line of research asks whether creatine does anything for blood vessels themselves, not just muscle and brain energetics. Small early trials point the same direction: a 2024 pilot in sedentary older adults found four weeks of creatine improved both large- and small-vessel endothelial function (flow-mediated dilation) versus placebo, a 2025 microdialysis pilot found creatine enhanced postprandial blood flow in skeletal-muscle microvessels — plausibly by curbing NADPH-oxidase-derived reactive oxygen species — and a placebo-controlled trial in vegans found creatine lowered homocysteine and raised skin capillary density and microvascular reactivity.

Treat this as preliminary, not established. Every one of these is a tiny pilot reading a surrogate endpoint (vessel-function markers), not hard cardiovascular outcomes. The counter-signal: an older RCT in coronary-artery-disease patients found creatine had no effect on flow-mediated dilation and raised homocysteine. Vascular benefit is a hypothesis worth watching in healthy populations, not yet a reason to take creatine.

Creatine and women

Women have inherently lower creatine stores: 70–80% lower endogenous muscle creatine than men, ~20% lower creatine synthesis rate, and 30–40% lower dietary intake (especially in women who eat less red meat). This means the relative benefit of supplementation may be proportionally larger. Creatine does not make women “bulky” or masculinized: the 1–2 kg is intracellular water, not fat, and creatine has no androgenic action.

Life-stage considerations:

• Menstrual cycle: hormonal fluctuations affect creatine kinetics. Estrogen influences creatine transporter expression. Earlier studies that showed weak results in women often failed to control for cycle phase.
• Pregnancy: creatine demand rises in pregnancy, and animal models show it protects the fetal brain and organs during birth complications (hypoxia). But human supplementation trials are limited, so creatine is not yet a recommendation in pregnancy — an area to watch, not to act on.
• Post-menopause: loss of estrogen-mediated creatine support coincides with accelerated sarcopenia and bone loss. Creatine combined with resistance training produces small but real gains in lean mass and strength in post-menopausal women (2026 meta-analysis) — though the largest 2-year trial found no change in bone mineral density itself. The durable benefit here is muscle and function, not bone density.
• Mood: meta-analyses of creatine as an SSRI adjunct show larger effects in women, likely linked to sex-specific differences in brain energy metabolism — though the pooled antidepressant effect is small and below the clinically meaningful threshold (see Brain → Mood and depression above), so treat it as a modest adjunct, not a standalone treatment.

Doses

Creatine Calculator — muscle, brain, vegan, and sleep-deprived protocols→

• 3–5g/day: muscle, performance, and general health; no loading required, steady-state saturation in ~4 weeks; ~0.1 g/kg of body weight per day is a more precise estimate
• 5–10g/day: used in cognitive trials showing benefit in older adults, sleep-deprived individuals, and vegetarians; higher dose does not produce large cognitive gains in healthy young adults at rest
• Sleep deprivation context: brain creatine uptake is less efficient than muscle; sleep deprivation trials used loading doses (20g/day × 7 days, 2006) or a single high dose (0.35 g/kg body mass, ~25g for a 70kg person, 2024); both improved cognitive performance under sleep loss and increased cerebral phosphocreatine; daily doses above the standard 3–5g may provide more brain support when sleep is compromised
• Loading protocol (optional): 20g/day split into 4 × 5g doses for 5–7 days to saturate faster, then drop to maintenance: reaches the same endpoint as gradual dosing ~3 weeks sooner
• Timing: post-workout may have a slight edge over pre-workout for muscle creatine uptake (likely due to increased blood flow and insulin-mediated transport), but consistency matters far more than timing: take it whenever you’ll remember daily
• Absorption is enhanced when taken with carbohydrates or electrolytes (insulin-mediated creatine uptake via the creatine transporter, SLC6A8)

Food sources

A typical omnivore diet provides ~1–2g/day. Vegetarians and vegans get near-zero from food — they rely entirely on endogenous synthesis (~1–2g/day), which means their total body creatine stores are consistently lower. This is why vegetarians show the largest response to supplementation, both for muscle and brain outcomes.

The mirror image is the so-called “non-responder”: people who already eat a lot of red meat and fish start with fuller muscle stores, so they have less room to gain. Most apparent non-response is really a high baseline — not a failure of the supplement — and most people reach a similar saturation ceiling given enough time, though, as below, fuller stores do not guarantee a proportionally larger performance gain.

This baseline difference is measurable. A controlled trial across children, omnivores, vegetarians, and the elderly found that a short course of creatine raised muscle phosphocreatine most in vegetarians and the elderly, but not significantly in omnivores — diet shapes who has room to respond. A systematic review concludes vegetarian athletes are likely to benefit from supplementation, though the evidence is mixed on whether their performance gains exceed omnivores’; one small 2025 RCT in vegans raised muscle creatine after a week but saw no change in sprint power, so the larger stores response does not automatically translate into a larger performance response. Low dietary creatine intake is, in any case, common on restricted and plant-forward diets (an industry-funded 2026 survey analysis) — a reasonable rationale for vegetarians and vegans to supplement.

Cooking degrades some creatine (heat converts it to creatinine), so raw/rare preparations retain more — though the practical difference is small.

Creatine forms comparison

Bottom line: Creatine monohydrate has hundreds of RCTs establishing its safety and efficacy. A 2024 head-to-head RCT found HCl “showed no benefit over monohydrate” for strength, body composition, or hormonal responses, and a 2022 double-blind RCT of the trademarked “super creatine” (creatyl-L-leucine) found it did not raise muscle creatine content at all over 14 days, while plain monohydrate did. Higher solubility ≠ higher bioavailability in the human GI tract — micronised monohydrate is already ~95% absorbed.

Creatine gummies: the 2025 hype trap

Creatine gummies are marketed as an easy daily dose, but the format fights the molecule. Making a gummy needs heat (pectin gels at ~180–200°F) and acid (citric acid for flavour) in a moist matrix, the exact conditions that convert creatine into inert creatinine. Independent HPLC (high-performance liquid chromatography) testing in 2024–2025 confirmed this is not theoretical: of 12 gummy brands one supplement maker tested, half failed their label claim, and a separate panel found 4 of 6 popular gummies contained almost no creatine, with one Amazon best-seller delivering 0.005 g against a 5 g claim (both test reports are linked under Sources below). Buy plain monohydrate powder for the proven 3–5 g; treat any creatine gummy as guilty until a recent third-party assay proves the dose survived the jar.

Side effects and common concerns

Confirmed side effects

The reassuring baseline: a 2025 analysis pooling 685 creatine trials (12,839 people supplemented) found no increase in the prevalence or frequency of side effects versus placebo. The genuinely confirmed effects are minor and mechanical:

• Water retention: 1–2kg bodyweight increase from intracellular volumisation (water drawn into muscle cells), not fat or subcutaneous bloating. Normalises if supplementation stops.
• GI (gut) discomfort: only at high single doses (>10g at once); split doses eliminate this almost entirely. HCl may cause fewer GI issues at high doses due to solubility, but this doesn’t justify its cost premium for standard dosing.
• Creatinine elevation in bloodwork: expected finding in anyone supplementing creatine. Creatine is non-enzymatically converted to creatinine (a waste product filtered by kidneys). This raises serum creatinine, which falsely lowers estimated GFR (eGFR) on standard blood panels. If your doctor sees a low eGFR while you’re on creatine, tell them that a cystatin C–based GFR estimate (an alternative kidney-filtration marker creatine does not distort) is unaffected and should be used instead.

Loading, cycling, and bloating

• Loading is optional: a 20g/day × 5–7 day load only reaches saturation ~3 weeks sooner than plain 3–5g/day; the endpoint is identical.
• Cycling is unnecessary: there is no need to cycle off creatine. Continuous daily use is how the long-term safety data (up to 30g/day for 5 years) were generated.
• The “bloat” is intracellular, not subcutaneous: the 1–2 kg is water drawn into muscle cells (cell volumisation), not the puffy, under-the-skin water people picture; it does not make you look soft.

Caffeine (does it cancel creatine?)

A persistent gym myth says caffeine “cancels out” creatine — it traces to a single 1996 study in which caffeine abolished creatine’s strength benefit. The fuller picture, from a 2022 systematic review of the interaction: taking caffeine acutely (your pre-workout, your morning coffee) alongside creatine does not blunt creatine’s effect; the only signal of interference comes from chronic, high caffeine intake during a creatine loading phase. Practical translation: coffee and creatine are fine together. If you habitually megadose caffeine, just don’t pair it with a high loading dose in the same window.

Hair loss (DHT myth)

This is the single most common concern about creatine. The evidence:

• Origin: one small 2009 RCT (n=20 rugby players) found DHT (dihydrotestosterone) increased 56% during loading. DHT is linked to male pattern baldness.
• The study did NOT measure hair loss: only hormone levels. DHT remained within normal physiological range.
• Not replicated since: in the 15+ years since, no other trial has reproduced a DHT or testosterone change from creatine — that 2009 trial remains the lone outlier.
• Directly refuted: a 2025 RCT measuring actual hair density, follicle health, and hormone levels found no differences between creatine and placebo groups.
• The 2017 ISSN position stand does not list hair loss as a side effect.

Verdict: there is no credible evidence that creatine causes hair loss. The concern originates from a single unreplicated study that measured hormones, not hair.

Kidney concerns

No adverse renal effects have been found in healthy individuals at any studied dose (up to 30g/day for 5 years). A 2025 meta-analysis of 21 studies confirms this directly: creatine causes only a modest, transient rise in serum creatinine (metabolic turnover, not kidney injury), with no change in glomerular filtration rate (GFR). A 2026 meta-analysis puts numbers on the split that causes the confusion: serum creatinine rose (+0.13 mg/dL across 19 trials) while urea and eGFR both showed no difference. That gap is the whole story. Creatinine is a breakdown product of creatine, so taking more of it raises the marker your doctor reads as a kidney proxy without the kidney doing anything differently. If a routine panel flags high creatinine and you supplement, say so before anyone investigates further. Pre-existing kidney disease is a contraindication — consult a doctor. The ISSN position stand explicitly states creatine is safe for kidneys in healthy populations.

Cancer: a two-sided mouse story, and an empty human box

A claim circulating on social media says creatine prevents cancer. A mirror-image claim says it causes cancer. Start with the fact that settles both: no study has ever tested whether taking creatine changes a person’s chance of getting cancer. Not one trial, not one prospective follow-up of supplement users. A 2026 systematic review screened 230 articles on creatine in cancer models and found the evidence entirely preclinical, with the animal results openly conflicting.

The tumor-fighting side, and what it tested. Creatine fuels the immune cells that attack tumors. Knocking out the creatine transporter cripples CD8 T-cell antitumor immunity, and supplementing mice suppressed tumor growth across several models (2019). Later work found the same through macrophages (2023), dendritic cells (2026), and a ferroptosis pathway in colorectal cancer (2025). Read the design, not the headline: in these studies the tumor was already there before the creatine was given. They are experiments about treating cancer in mice, not about preventing it in people. “Prevents cancer” requires two leaps at once, from mouse to human and from treatment to prevention.

The tumor-helping side. A 2021 study reported the opposite direction: creatine promoted colorectal and breast cancer metastasis and shortened survival, with the authors explicitly calling for caution about dietary creatine. Note that this is the same cancer type where the ferroptosis paper found benefit, which is how unsettled this literature is. A second mechanism landed in July of 2026: creatine raises creatine kinase B in megakaryocytes, the cells that make platelets, driving platelet hyperactivity via STAT5B, and platelets are what shield tumor cells travelling in the blood. This one did not stop at mice — supplementation made healthy human volunteers’ platelets hyperactive. Eleven volunteers, aged 20–25, took 20 g/day for 14 days, with no placebo and no control group — each person was compared against their own day-0 baseline. Twenty grams a day is four to six times the 3–5 g maintenance dose above; it is the classic loading dose, except loading normally runs five to seven days before dropping down, and here it ran for the full fortnight. No human developed or was assessed for cancer. The metastasis half of that headline comes from taking those volunteers’ platelets and injecting them into mice alongside tumor cells. The authors say it plainly: “Although our human data is preliminary”. So what the data show is that a sustained loading dose measurably changed platelet behaviour in eleven young adults, and nobody has tested whether a maintenance dose does anything of the kind.

The population data is weaker than it looks. A 2024 cross-sectional analysis of 25,879 US adults found higher dietary creatine intake associated with lower cancer prevalence, most clearly in older adults. It cannot carry much weight. A single-timepoint snapshot cannot show that the intake came before the diagnosis rather than after it, the exposure is creatine from meat rather than powder, and people already diagnosed with cancer frequently eat less meat — which would manufacture this exact association with no causal link at all.

The one older worry, raised and then closed. A 2015 case-control study found men who had ever used muscle-building supplements had elevated testicular cancer risk. The exposure there was a whole product class including hormonally active agents, so it could not pin anything on creatine. The proposed mechanism — that creatine forms carcinogenic heterocyclic amines — was then tested head-on in humans and came back negative, as it did in pigs fed up to 50 g a day. Those compounds form when meat is seared at high heat, not when powder dissolves in water.

What human trials do exist. They are in people who already have cancer, and they are about muscle, not tumors. The largest (2017) randomized 263 patients with advanced cancer against placebo: no effect on weight, appetite, grip strength or quality of life, and median survival of 230 versus 239 days. A 2025 systematic review of seven trials in cancer patients and survivors found body-composition differences that did not reach significance. Useful to know, but supportive care is a different question from prevention and cannot be borrowed to answer it.

Verdict: nobody knows, because the study has not been done. Every tumor-growth and metastasis result above is animal work pointing in both directions, often at creatine doses far beyond what a person takes — and the one human signal came from a 20 g/day loading dose in eleven people with no control group, not from anything resembling the 3–5 g/day recommended above. A 2025 safety review concluded the evidence does not support a creatine-cancer link, though it predates the platelet mechanism. None of this is a reason to stop taking creatine — the “it feeds cancer cells” logic would indict protein and glucose equally, and your own body makes creatine every day. It is a reason to distrust anyone selling you either headline. If you have active cancer or a known elevated risk, raise it with your oncologist, because the one genuinely open animal question is about existing tumors spreading rather than about healthy people developing cancer.

Creatine and aging

Beyond brain benefits, creatine has emerging relevance for healthy aging:

• Sarcopenia: creatine combined with resistance training produces greater gains in lean mass and strength in older adults compared to resistance training alone, and a 2025 review extends the same muscle, strength, bone-geometry and functional benefits to clinical populations. Given that muscle is the largest predictor of all-cause mortality (see muscle module), this combination is one of the most evidence-supported anti-aging strategies available.
• Bone health: the bone-density story is weaker than once hoped. The largest, longest trial — 2 years in 237 post-menopausal women (2023) — found no effect on bone mineral density at any site, and a 2026 meta-analysis concludes bone-density effects “remain unclear”. What creatine + training reliably preserves is muscle, plus some femoral-neck bone geometry (a strength surrogate the trial’s own authors call sub-threshold for fracture prevention). Treat creatine as a muscle-and-strength tool in aging, not a bone-density drug.
• Mitochondrial function: creatine supports the PCr shuttle, which becomes increasingly important as mitochondrial efficiency declines with age. See the ATP metabolism module for full mitochondrial context.

Creatine during GLP-1 (Ozempic-era) weight loss — emerging

GLP-1 receptor agonists (semaglutide, tirzepatide) drive fast weight loss — but a large share of what comes off is lean mass, not just fat, which risks leaving people weaker and metabolically worse off. Creatine has entered this conversation as a cheap adjunct for defending muscle during the drop. Two reviews from 2025–2026 list creatine (alongside resistance training and adequate protein) among the supplements plausibly worth using to retain lean mass and strength through GLP-1 therapy.

Read this as plausible extrapolation, not proven in this context. The support is indirect — it borrows creatine’s well-established muscle-and-strength evidence and points it at the GLP-1 population, where dedicated randomized evidence is still pending. If you are on a GLP-1 drug, creatine plus resistance training and protein is a reasonable, safe bet for protecting muscle; just don’t expect a head-to-head trial to have proved it yet.

Regulatory and sport status

Creatine is sold as a food supplement, not a drug, and is not on the WADA (World Anti-Doping Agency) Prohibited List — it is permitted in tested sport by the major anti-doping bodies. The one practical caveat for a tested athlete is contamination, not the molecule: choose a batch-tested (NSF Certified for Sport / Informed-Sport) product so a cheap, unverified powder cannot introduce a banned substance. The scale of that risk is not hypothetical. When Sport Integrity Australia had 200 sports supplements bought off the Australian market and analysed (2025), 35% contained WADA-prohibited substances, and 57% of those did not list them on the label. Two caveats apply: the survey reports no creatine-specific rate, and the categories it names as worst are pre-workouts, fat burners and muscle builders rather than single-ingredient monohydrate. So buy certified: the survey gives no reason to fear creatine itself, and if you are drug-tested, “it was just creatine” is not a defence an unlabelled stimulant will respect.

How to judge creatine on the shelf

Creatine is cheap and effective, so the buying decision is almost entirely about form and source: plain monohydrate from a named, verified raw-material supplier. The “advanced” forms are the trap, and the marketplace data says so plainly. A 2022 audit of 175 alternative creatine products found roughly 88% had limited-to-no evidence behind their bioavailability, efficacy and safety claims, while monohydrate cost about a third as much per gram. The standing critical review (2022) reaches the same verdict: monohydrate “continues to be the only source of creatine that has substantial evidence”. Note who is talking, though — that review’s authors carry extensive industry ties, which is worth knowing even when the conclusion happens to point at the cheapest option on the shelf.

Look for:

• Creapure or Creavitalis branded mark
• Monohydrate form
• Independent third-party testing (NSF / Informed-Sport or your region’s equivalent) — for tested athletes, batch-tested product guards against cross-contamination

Avoid:

• HCl / ethyl-ester / “advanced” forms
• China-bulk / unnamed source
• Added artificial sweeteners (sucralose, saccharin, acesulfame-K), flavours, or fillers — plain monohydrate is a single odourless ingredient and needs none
• Gummy / chewable format — heat + acid degrade the dose to creatinine; many test underdosed (verify a recent third-party assay)

The buying decision

• Verdict: ✅ approved
• Buy: creatine monohydrate — the evidence-backed form; HCl and ethyl ester are unproven. See vetted products on klatiAPPROVED
• Avoid: creatine HCl, creatine ethyl ester, China-bulk creatine — see klatiBAN
• Dose: 3–5g/day — calculate yours on klatiCALC
• No referral fee on this product. Full disclosure.

Sources

⚠️ Only use ultra-clean certified creatine. Raw material source matters — contaminated creatine exists and is widely sold. Two certified manufacturers: Creapure (Germany, AlzChem) and Creavitalis (Netherlands). Any brand is fine as long as they explicitly state one of these as their raw material source.

• China-sourced raw material contains high levels of dicyandiamide (DCD) and dihydrotriazine: ☠️ byproducts of cheap synthesis
• most brands just repack bulk raw material: they do not manufacture it themselves; the raw material source is what matters
• creatine gummy lab tests: 12-brand HPLC test and 6-gummy panel
• check klatiAPPROVED for klati approved sources

Research